The synthesis and structure-activity relationship (SAR) studies of praziquantel derivatives with activity against adult Schistosoma japonicum are described. Several of them showed better worm killing activity than praziquantel and could serve as leads for further optimization.
Introduction
Schistosomiasis is a neglected tropical disease (NTD) caused by blood-dwelling trematodes belonging to the genus Schistosoma. Schistosoma haematobium, Schistosoma japonicum, and
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Schistosoma mansoni are the main species parasitizing humans [1] . It has been estimated that some 779 million people are at risk for schistosomiasis transmission, with 207 million infected in 76 countries and territories [1, 2] . In China, the disease caused by Schistosoma japonicum remains a major public health concern with more than 280 thousand people infected [3] . In the absence of a vaccine, praziquantel (PZQ) has been the only drug recommended by the World Health Organization for the treatment and control of schistosomiasis through mass drug administration (MDA) programs for almost three decades [4] . However, PZQ does not prevent reinfection, and it is inactive against juvenile schistosomes. Furthermore, it has only a limited effect on developed liver and spleen lesions, as well as on the emergent schistosome phenotypes that are resistant to PZQ chemotherapy [5, 6] . Therefore, it is imperative to develop new antischistosomal agents. A number of recent studies were directed towards exploration of new chemical entities from natural products [7] [8] [9] [10] and towards the identification of additional drug targets for schistosomiasis [11] [12] [13] [14] [15] .
In addition, there are two other major issues with regard to PZQ: (1) the mechanism of action of PZQ is uncertain [16] and (2) as currently administered, PZQ is a racemic mixture [16] . It is a great challenge to prepare (−)-PZQ inexpensively and stereoselectively [17] . The less active (+)-PZQ enantiomer has well been documented as having a bitter and disgusting taste [18] . Recently, many synthetic routes for PZQ and its derivatives have been developed [19, 20] , providing more opportunities to make novel PZQ derivatives as potential drugs for the treatment of schistosomiasis. Ever since the discovery of PZQ, there has been interest in the elucidation of the structure-activity relationships (SAR) [21] , mostly from data generated using S. mansoni, and to some extent with data for S. japonicum. There are five positions amenable for chemical modification in the PZQ molecular structure [16, 22] (Figure 1 ). Among these, only position R 1 has been heavily investigated [21] . Recently, more variants at the R 1 position as well as PZQ-ozonide hybrids were synthesized and tested against juvenile and adult stages of S. mansoni in vitro and in vivo. Unfortunately, all the variants showed decreased activity compared to the parent compound PZQ [23] . Patra and co-workers reported PZQ analogues that replaced the cyclohexyl group at position 2 with different ferrocenyl moieties. Unfortunately, the Fc-PZQ derivatives were considerably less active than PZQ when tested against S. mansoni in vitro [22] . Recently, Gasser and coworkers reported Cr-PZQ derivatives with comparable antischistosomal activities to PZQ when tested against adult S. mansoni [24] . In 2007, the Todd group first reported several derivatives through nitration and amination of the C10 position of the aromatic ring on PZQ. However, these compounds showed significantly decreased worm killing activity against S. mansoni in vitro [25] . In 2012, the Qiao group synthesized eight PZQ/peroxide conjugates, with some compounds showing superior worm-killing activity against S. japonicum in in vitro assays compared to PZQ [26] . Recently, the Qiao group reported aromatic ring-modified praziquantel derivatives with activity against both juvenile and adult S. japonicum, and a compound with a bromide atom at C8 position showed higher potency against adult S. japonicum than PZQ in vitro and comparable antischistosomal activity to PZQ in vivo. However, none of them showed superior worm-killing ability to PZQ [27] . The Rao group developed an efficient synthetic route to provide structurally diverse analogues for SAR studies. Several PZQ analogues with an indol ring were synthesized and tested against adult S. mansoni. Unfortunately, no compounds showed better activity than PZQ in vitro [28] . Taken together, all this data indicates that although much work has been done on PZQ, it is still necessary to further expand the range of PZQ analogues in order to obtain chemical probes to elucidate the real biological mechanism of PZQ, and to generate alternative new chemotherapies. Therefore, we became interested in the synthesis of new PZQ analogues to find new potential antischistosomal agents against S. japonicum.
Results and Discussion

Chemistry
Due to the lack of SAR details from S. japonicum, we initially resynthesized some PZQ analogues with position 2 substitution and evaluated their worm-killing activities against S. japonicum (Scheme 1). The racemic PZQ from Aldrich was hydrolyzed by 2 N HCl to yield praziquanamine (1) using the method described by the Vennerstrom group [23] , followed by coupling with acyl chlorides to yield compounds 2-12. Reductive amination reactions of appropriate aldehydes with praziquanamine (1) were performed with sodium triacetoxyborohydride in dichloroethane at room temperature to afford compounds 13-15 in yields ranging from 27% to 35%. Praziquanamine (1) was reduced by lithium aluminum hydride to yield compound 16, followed by acylation to yield compounds 17-22. To extend the SAR studies, the aromatic moiety was replaced by a thiophene ring, and compound 23 was synthesized using the method described by Frehel and his coworkers [29] . Compound 23 was hydrolyzed with 2N HCl to yield amine 24, followed by acylation with appropriate acyl chlorides to yield compounds 25-33 (Scheme 2). As in previous reports [22] , we also observed the major isomer in mixtures with its minor enantiomer with respect to the 11b position on the ring system for compounds 1-33. The results were also in agreement with the nature of the commercially available PZQ [19, 30] and its thiophene analogue 23 [20] . 
Biological Activities
The biological results are listed in Table 1 . Among compounds with an aliphatic cyclic ring (2-4 and PZQ), the worm-killing activity was improved by increasing the ring size. Compounds with an acetyl group (i.e., 5) and with an isobutyryl group (i.e., 6) lacked worm-killing activity. Among compounds with a halogen atom, compound 7 with the chloroacetyl group killed 100% of the worms at the concentration of 5 M, showing better activity than PZQ. However, compound 8 with a 2,2,2-trifluoroacetyl group lost worm killing activity. Replacement of the cyclohexyl ring with a heterocyclic ring, (compound 11 with a thiophene-2-carbonyl group) led to a similar activity to that of PZQ. However, compound 10 with an isonicotinoyl group and compound 12 with a furan-2-carbonyl group did not show any worm-killing activity below the concentration of 100 M. Compound 9, with a benzoyl group, showed similar activity as PZQ. Replacement of the carbonyl group at position 2 with CH 2 gave compounds 13-15, which showed no worm-killing activity. The results indicated that the amide bond at position 2 is essential for activity against S. japonicum. The SAR results displayed similarities between compounds 17-22 and compounds containing amide (3, 4, PZQ, 9, 11, and 7), showing decreased activity. The results indicated that the amide bond at position 4 was very important to maintain the activity of PZQ derivatives. The SAR results from S. japonicum adult worms were similar with those from S. mansoni [21] . However, it still gave us valuable information to explore novel PZQ derivatives as antischistosomal agents.
To enlarge the chemical space of potential drug candidates, replacement of the phenyl ring on PZQ with a thiophene ring gave compounds 23-33. Among compounds with an alkyl group (i.e., 23, 25-29), compound 23 with a cyclohexanecarbonyl group showed the best worm-killing activity, and it showed similar activity to PZQ. However, the worm-killing activity of compounds 24-29 was dramatically decreased. The amine-containing compound 24 had no activity. Among compounds with an aromatic ring, compound 30 with a benzoyl group showed slight worm-killing activity, while compound 31 with a thiophene-2-carbonyl group and compound 32 with a furan-2-carbonyl group had no activity. Interestingly, compound 33 with a chloroacetyl group showed good worm killing activity at 10 M, similar to PZQ derivative 7. Among the compounds reported here, compounds 7, 22 and 33 with a chloroacetyl group showed better antischistosomal activity than PZQ. The evaluation of their cytotoxity is in progress. There have been many compounds with a chloroacetyl group under development [31] [32] [33] . For example, TNP470 [O-(chloroacetylcarbamoyl)fumagillol], which was derived from the natural product fumagillin, was in clinical trials for Kaposi's sarcoma [34] , as well as renal, brain, breast, cervical and prostate cancers [35] . 
Experimental
Chemistry
All chemicals were reagent grade and used as purchased. All reactions were performed under an inert atmosphere of dry argon or nitrogen using distilled dry solvent. 1 A mixture of PZQ (10 g, 32 mmol) and 2 N HCl (50 mL) was refluxed overnight. After PZQ was consumed, the reaction solution was cooled to room temperature, neutralized with NaHCO 3 (aq.) and then extracted with DCM/MeOH (V/V 10/1, 100 mL × 3). The organic layer was washed with water and brine, dried with anhydrous Na 2 SO 4 and concentrated to get the crude product. The crude product was washed with petroleum ether/EtOAc (V/V 10/1) to yield compound 1 (4 g, 62%) as a yellow solid. 
Procedure for the Preparation of Compound 8
A stirred solution of compound 1 (500 mg, 2.5 mmol) in DCM (20 mL) was added to trifluoroacetic anhydride (275 L, 2 mmol) and triethylamine (275 L, 2 mmol). After the addition, the mixture was stirred at room temperature overnight. The reaction residue was poured into water, and extracted with EtOAc (50 mL × 3). The organic phases were then processed in the usual way and chromatographed (1:1 petroleum ether/EtOAc) to afford compound 8 (450 mg, 62%) as a white solid. 
General Procedure for the Preparation of Derivatives 2-7 and 9-12
A stirred solution of compound 1 (500 mg, 2.5 mmol) in DCM (50 mL) was added to cyclopropanecarbonyl chloride (420 L, 3.7 mmol) at 0 °C slowly. After the addition, the mixture was stirred at room temperature overnight. The reaction residue was poured into NaHCO 3 (aq.), extracted with DCM (250 mL), washed with water and brine/dried over Na 2 SO 4 . The organic phases were then processed in the usual way and chromatographed (1:1 petroleum ether/EtOAc) to afforded compound 2 (350 mg, 49%). 
2-(Cyclobutanecarbonyl)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (3)
.
2-(Cyclopentanecarbonyl)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (4)
2-Acetyl-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (5)
2-Benzoyl-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (9
2-(Thiophene-2-carbonyl)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (11
2-(Furan-2-carbonyl)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (12
General Procedure for the Preparation of Derivatives 13-15
To a solution of compound 1 (305 mg, 1.5 mmol) in methanol (10 mL), cyclohexanecarbaldehyde (186 μL, 1.5 mmol) was added at 0 °C, followed by acetic acid (170 L, 3.0 mmol) addition. The mixture was thus maintained at 0 °C for 1 h. Then it was heated at 60 °C for 2 h. After cooled to 0 °C, NaBH 4 (0.45 g, 12.0 mmol) was added by portions. The reaction mixture was stirred at 60-70 °C for 12 h, followed by evaporation to remove methanol. The residue was diluted with water (30 mL) and extracted with ethyl acetate (30 mL × 3). The organic phases were then processed in the usual way and chromatographed (2:1 petroleum ether/EtOAc) to afforded compound 13 (140 mg, 32%) as a white solid. 1 Benzyl-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (14 
2-
Procedure for the Preparation of Compound 16
Compound 1 (3.03 g, 15 mmol) was added to a solution of lithium aluminum hydride (1.14 g, 30 mmol) in tetrahydrofuran (63 mL) and the mixture was refluxed for 10 h After cooled to 0 °C, the reaction was quenched with aqueous sodium hydroxide (15%, 1.2 mL), and the precipitate was filtrated. The organic phases were then processed in the usual way and chromatographed (10:1 CH 2 Cl 2 /MeOH) to afforded compound 16 (1 g, 35%) as red oil. 
General Procedure for the Preparation of Derivatives 17-22
To a stirred solution of compound 16 (500 mg, 2.7 mmol) in DCM (50 mL), cyclohexanecarbonyl chloride (532 L, 4.0 mmol) was added at 0 °C. The mixture was stirred at room temperature overnight. The reaction was quenched with NaHCO 3 (aq.), extracted with DCM (50 mL × 3). The organic phases were then processed in the usual way and chromatographed (1:1 petroleum ether/ EtOAc) to afforded compound 19 (350 mg, 43%) as white solid. Cyclobutyl (3,4,6,7-tetrahydro-1H-pyrazino [2,1-a] isoquinolin-2(11bH)-yl)methanone (17) . Yield = 35%; Cyclopentyl (3,4,6,7- (22) . Yield = 36%; 
2-Chloro-1-(3,4,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-2(11bH)-yl)ethanone
General Procedure for the Preparation of Compound 25-33
To a stirred solution of compound 24 (208 mg, 1 mmol) in DCM (10 mL), cyclobutanecarbonyl chloride (136 L, 1.2 mmol) was added and stirred at room temperature overnight. The reaction was quenched with NaHCO 3 (aq.), extracted with DCM. The organic phases were then processed in the usual way and chromatographed (1:1 petroleum ether/EtOAc) to afforded compound 26 (150 mg, 52%). (29) . Yield = 76%; 
2-Pivaloyl-2,3,6,7-tetrahydro-1H-thieno[3',2':3,4]pyrido[1,2-a]pyrazin-4(10bH)-one
